Unusual CNS presentation of thyroid cancer

Clinical Neurology and Neurosurgery

Volumn 114, Issue 7, 2012, Pages 1107-1109

  Heery, Christopher R ^a   Engelhard, Herbert H ^a   Slavin, Konstantin V ^a   Michals, Edward A ^a   Villano, J Lee ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Brain tumor; CNS; Metastases; Thyroid cancer

Indexed keywords

LIOTHYRONINE; METOPROLOL; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THYROGLOBULIN; THYROID TRANSCRIPTION FACTOR 1; THYROTROPIN; THYROXINE;

ADRENALECTOMY; ADULT; AGED; AMNESIA; ARTICLE; ATAXIA; BRAIN TUMOR; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CRANIOTOMY; DIFFERENTIATED THYROID CANCER; DYSARTHRIA; FEMALE; FOLLICULAR CARCINOMA; HUMAN; HYDROCEPHALUS; MALE; RECURRENT DISEASE; STEREOTACTIC RADIOSURGERY; THYROID CARCINOMA; THYROIDECTOMY; THYROTOXICOSIS; URINE INCONTINENCE;

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, PAPILLARY, FOLLICULAR; COMBINED MODALITY THERAPY; DNA-BINDING PROTEINS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MITOSIS; RADIOSURGERY; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; THYROTOXICOSIS;

EID: 84864290006     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2012.01.004     Document Type: Article

References (18)

1. J. Sul, and J.B. Posner Brain metastases: epidemiology and pathophysiology Cancer Treat Res 136 2007 1 21
2. S.F. Dinneen, M.J. Valimaki, E.J. Bergstralh, J.R. Goellner, C.A. Gorman, and I.D. Hay Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades J Clin Endocrinol Metab 80 1995 2041 2045
3. W.M. McConahey, I.D. Hay, J.A. van Heerden, and W.F. Taylor Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome Mayo Clin Proc 61 1986 978 996
4. C. Zhang, F. Zhang, R. Tsan, and I.J. Fidler Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain Cancer Res 69 2009 828 835
5. H. Grinberg-Rashi, E. Ofek, M. Perelman, J. Skarda, P. Yaron, and M. Hajduch The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain Clin Cancer Res 15 2009 1755 1761
6. R.J. Aur, H.O. Hustu, M.S. Verzosa, A. Wood, and J.V. Simone Comparison of two methods of preventing central nervous system leukemia Blood 42 1973 349 357
7. T.B. Haddy, M.A. Adde, and I.T. Magrath CNS involvement in small noncleaved-cell lymphoma: is CNS disease per se a poor prognostic sign? J Clin Oncol 9 1991 1973 1982
8. R.R. McWilliams, C. Giannini, I.D. Hay, J.L. Atkinson, S.L. Stafford, and J.C. Buckner Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years Cancer 98 2003 356 362
9. M. Salvati, A. Frati, G. Rocchi, R. Masciangelo, A. Antonaci, and F.M. Gagliardi Single brain metastasis from thyroid cancer: report of twelve cases and review of the literature J Neurooncol 51 2001 33 40
10. L. Gaspar, C. Scott, M. Rotman, S. Asbell, T. Phillips, and T. Wasserman Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 37 1997 745 751
11. B.C. Pestalozzi, and S. Brignoli Trastuzumab in CSF J Clin Oncol 18 2000 2349 2351
12. C. Lin, S. Turner, H. Gurney, and A. Peduto Increased detections of leptomeningeal presentations in men with hormone refractory prostate cancer: an effect of improved systemic therapy? J Med Imaging Radiat Oncol 52 2008 376 381
13. E.C. de Lange, and M. Danhof Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain Clin Pharmacokinet 41 2002 691 703
14. H.R. Withers, and S.P. Lee Modeling growth kinetics and statistical distribution of oligometastases Semin Radiat Oncol 16 2006 111 119
15. S.A. Wells Jr., B.G. Robinson, R.F. Gagel, H. Dralle, J.A. Fagin, and M. Santoro Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial J Clin Oncol 30 2012 134 141
16. L.L. Carr, D.A. Mankoff, B.H. Goulart, K.D. Eaton, P.T. Capell, and E.M. Kell Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation Clin Cancer Res 16 2010 5260 5268
17. R.T. Kloos, M.D. Ringel, M.V. Knopp, N.C. Hall, M. King, and R. Stevens Phase II trial of sorafenib in metastatic thyroid cancer J Clin Oncol 27 2009 1675 1684
18. K.C. Bible, V.J. Suman, J.R. Molina, R.C. Smallridge, W.J. Maples, and M.E. Menefee Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study Lancet Oncol 11 2010 962 972